CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With Sarcoma

Clinical trial NCT03425279 · COMPLETED

Trial details

NCT number: NCT03425279
Sponsor: BioAtla, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Undifferentiated Pleomorphic Sarcoma Myxofibrosarcoma

Start date: 2018-02-15
Primary completion: 2025-01-08
Enrollment: 245

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.